AVANT GARDENERI was invited to the 10th Filipino Faces of Biotechnology (FoB) Awards presented by the Department of Agriculture Biotechnology Program Office ...
Get insights on AbCellera’s high valuation, AI-driven R&D losses, stock-based compensation, and how Canadian funding impacts ...
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...
No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.
No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following oral administration. MIAMI, FL / ACCESS Newswire / December 18, 2025 / ...
Former Gov. Jim Hunt, who redefined the office of governor in North Carolina, championed public education and helped focus ...
BioMarin said it is acquiring Amicus Therapeutics, maker of rare-disease drugs, for $4.8 billion. A new FDA program meant to ...
Insmed’s oral drug Brinsupri did not ease the burden of sinus symptoms in a mid-stage study of chronic rhinosinusitis without nasal polyps, forcing the New Jersey biotech to discontinue its program in ...
Whitestown resident Avrie Landaw recently described the moment she opened the email allowing her to pursue her childhood dreams. She said tears rolled down her face when she learned she’d been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback